CAS:736992-21-5|Elamipretide

Elamipretide (also known as MTP-131) is an experimental peptide-based drug that is being studied for its potential therapeutic use in a variety of diseases. It is a peptide drug composed of 31 amino acids, and is believed to be a mitochondrial-targeting peptide. Elamipretide has been studied for its potential to treat mitochondrial diseases, as well as for its antioxidant and cytoprotective properties. In addition, it has been studied for its potential to reduce inflammation, improve energy metabolism, and protect against oxidative damage.